Delivery Order SPE2DB20D2014-SPE2DB26FA17L
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexium DR 40 mg capsules (90-count) valued at $9,382.42. This firm fixed price, non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item delivery under the company's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Nexium DR 40 mg capsules (90-count units), valued at $1,187.34 under a firm fixed-price contract type. The award was made on October 23, 2025, with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nexium DR 40 mg capsules (90-count unit) with a ceiling value of $5,138.14. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,030.14 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count units). The contract, executed on October 20, 2025, with an ultimate completion date of October 21, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Nexium DR 40 mg capsules (90-count units) with a ceiling value of $1,687.56. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, represents a non-competitive set-aside contract and will be performed at the vendor's Conshohocken, Pennsylvania location. The award is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Nexium DR 40 mg capsules (90-count units) with a ceiling value of $9,251.86. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's...
- This delivery order, awarded on July 31, 2025, represents a $1,125.04 firm fixed-price procurement of NEXIUM DR 40 mg capsules (90-count units) through the Defense Logistics Agency's Medical Supply Chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received this non-set-aside award with an ultimate completion date of August 1, 2025. The contract is a child award under AmerisourceBergen's significantly larger Indefinite Delivery Contract (IDC) designated SPE2DX...
- The Defense Logistics Agency awarded a $6,680.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for 90-count bottles of Nexium DR 40 mg capsules, with completion scheduled for October 28, 2025. The award is unset-aside and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on September 24, 2025, for the supply of Nexium DR 40 mg capsules (90-count units) valued at $2,017.65. This is a firm fixed price, non-set-aside delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which carries a ceiling value of $999,999,999.00 and extends...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (30-count units) under a firm fixed-price contract type. The award, issued on September 22, 2025, carries a ceiling value of $1,125.12 and is scheduled for completion by September 23, 2025. This non-set-aside competitive award reflects the contractor's established capability to fulfill federal pharmaceutical procurement requirements through...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA17LDelivery Order
This delivery order, issued on October 23, 2025, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $1,125.04 for the supply of NEXIUM DR 40 mg capsules (90-count packages) to support federal pharmaceutical procurement needs. The contract is expected to be completed by October 24, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded order placed through the Defense Logistics Agency, which is responsible for medical supply chain management across the Department of Defense. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor contract valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply a broad portfolio of pharmaceutical products and medical supplies globally to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems across multiple therapeutic domains. The company's demonstrated capability to fulfill federal medical procurement requirements through open competition positions it as a critical vendor within the Defense Logistics Agency's Medical Supply Chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/23/25 |